Health Care & Life Sciences » Biotechnology | Sprint Bioscience AB

Sprint Bioscience AB

Sprint Bioscience AB
Stock Exchange First North Sweden
EPS
SEK1.75
Market Cap
SEK189.88 M
Shares Outstanding
10.1 M
Public Float
-

Profile

Address
Hälsovägen 7
Huddinge AB 141 57
Sweden
Employees -
Website http://www.sprintbioscience.com
Updated 09/14/2018
Sprint Bioscience AB engages in the business of drug development. It develops medicines in the field of cancer and metabolism. The company serves as preclinical part of the development process.

Financials

View All

Ingemar Kihlström
Director
Charlotta Liljebris
Director